|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 04/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 31/10/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 31/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| +0.10% | +0.44% | +2.80% | +24.32% | 51.14B | |
| +2.65% | +4.45% | +481.36% | +567.32% | 47.4B | |
| +0.33% | +2.47% | +38.97% | +19.80% | 43.19B | |
| -0.88% | +0.90% | +24.11% | +87.74% | 42.35B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.23B | |
| -1.21% | -0.17% | +29.16% | +135.38% | 17.07B | |
| -0.36% | -2.14% | - | - | 16.38B | |
| +0.25% | +0.25% | +12.03% | +30.68% | 14.76B | |
| +0.44% | +1.70% | +82.07% | +47.92% | 14.15B | |
| Average | -0.09% | +0.34% | +85.59% | +120.58% | 31.07B | |
| Weighted average by Cap. | +0.06% | +0.57% | +106.24% | +143.79% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
